PATH | VRL
Menu

Long-Term Immunogenicity of Measles Vaccine After Coadministration with Live Attenuated Japanese Encephalitis Vaccine

This follow-up study to PATH's original coadministration trial demonstrated that measles seroprotection rates were still high one year post-vaccination among infants who originally seroconverted for measles.

Author: PATH

Published: 2007

» Download file (English)

561 KB PDF

Resource types: PATH resource

Diseases/vaccines: Japanese encephalitis

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Asia